MTOR and non-small cell lung carcinoma: In Vitro: Doxorubicin induces apoptosis and UPR activation in NSCLC cells, with UPR preconditioning enhancing apoptosis via the eIF2α/mTOR pathway, while Tauroursodeoxycholate inhibits this effect